Key result
Inflammation mediates a brain-heart axis linking psychological stress and neuroinflammation to cardiovascular pathology.
Why the study?
Many individuals carry underrecognized residual cardiovascular risk secondary to systemic inflammation, and growing evidence implicates inflammation in mediating an interconnected brain-heart axis.
This review highlights the emerging brain-heart axis, where psychological stress and neuroinflammation drive cardiovascular pathology, suggesting novel therapeutic targets beyond traditional risk factors.
Answers are grounded in this paper and cite their sources.
May inform stress assessment in CVD risk evaluation; leaves open brain-heart axis interventions pending prospective trials.
Cardiovascular disease remains the leading cause of death worldwide, with a rising burden projected over the coming decades. Although traditional risk factors such as diabetes, hypertension, and dyslipidemia form the main targets of prevention strategies, many individuals carry a "residual" risk secondary to systemic inflammation which remains underrecognized. Landmark trials have established inflammation as a causal and modifiable driver of atherosclerotic cardiovascular disease. This review focuses on how inflammation can modulate interconnected diseases of the brain and heart. Growing evidence suggests that inflammation mediates a "brain-heart" axis, linking psychological stress, neuroinflammation, and cardiovascular pathology. Observational and mechanistic studies demonstrate that stress-induced neural activity, particularly within the amygdala, is associated with hematopoietic activation, arterial inflammation, and increased cardiovascular events. Models such as Takotsubo's cardiomyopathy and stroke-heart syndrome illustrate how acute brain injury can precipitate cardiovascular dysfunction via autonomic and inflammatory pathways. More recently, molecular imaging studies have provided direct evidence of stress-associated amygdalar activity being associated with both cardiovascular outcomes and cancer prognosis. This emerging framework reframes the brain and heart as interdependent organs connected through inflammatory and neurobiological processes, highlighting the potential for novel therapeutic targets, including modulation of stress-related neural pathways, alongside established anti-inflammatory strategies. Future directions include refinement of targeted therapies, use of advanced molecular imaging, and mechanistic studies to better delineate the pathways linking stress, inflammation, and cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Hakimjavadi et al. (2025) conducted a review in Cardiovascular disease. Inflammation and stress-related neural pathways was evaluated. Inflammation mediates a brain-heart axis linking psychological stress and neuroinflammation to cardiovascular pathology, highlighting potential novel therapeutic targets.
Synapse has enriched 10 related papers. Consider them for comparative context: